Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
ViewAttendees 2

Roller Coaster 4 - Birds of a Feather 5

A mechanistic model to inform step-up dosing that limits cytokine release following a bispecific T cell engaging antibody treatment for B-cell lymphomas

Wednesday, November 13, 2024
11:05 AM – 11:20 AM MST
Location: Kaibab & Lantana

    Speaker(s)

  • VH

    Vincent Hurez, DVM, PhD (he/him/his)

    Director Group Quantitative Pharmacology
    Regeneron Pharmaceuticals Inc.
    Tarrytown, New York, United States

    Disclosure(s): Regeneron Pharmaceuticals, Inc.: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

    PDF Slides
Disclosure(s):
Vincent Hurez, DVM, PhD: Regeneron Pharmaceuticals, Inc.: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)